Opes Advisors’s Celgene Corp CELG Stock Holding History

Opes Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-13,374	Closed	-$1.95M	–	51
2017 Q3	$1.95M	Hold	13,374	–	–	1.25%	22
2017 Q2	$1.79M	Sell	13,374 -1,689	-11%	-$207K	1.11%	22
2017 Q1	$1.87M	Buy	+15,063	New	+$1.8M	1.32%	21

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Opes Advisors's CELG Position: Q4 2017 in Review

Opes Advisors sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 13,374 shares — an estimated $1.95M sold.

Opes Advisors first reported a position in CELG in Q1 2017 and held it in 3 quarters. The position peaked at $1.95M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

Opes Advisors reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
Opes Advisors sold 13,374 Celgene Corp shares in Q4 2017, an estimated $1.95M.
Opes Advisors first reported a position in Celgene Corp in Q1 2017 and held it in 3 quarters.
Opes Advisors's Celgene Corp position peaked at $1.95M in Q3 2017.
1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Opes Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.